Central Surgical Association| Volume 128, ISSUE 4, P540-547, October 2000

Surgical shunts and tips for variceal decompression in the 1990s


      Background. In the 1990s, liver transplantations and transjugular intrahepatic portosystemic shunts (TIPS) have become the most common methods to decompress portal hypertension. This center has continued to use surgical shunts for variceal bleeding in good-risk patients who continue to bleed through endoscopic and pharmacologic treatment. This article reports this center's experience with surgical shunts and TIPS shunts from 1992 through 1999. Methods. Sixty-three patients (Child A, 43 patients; Child B, 20 patients) received surgical shunts: distal splenorenal, 54 patients; splenocaval, 4 patients; coronary caval, 1 patient; and mesocaval, 4 patients. Sixty-two patients had refractory variceal bleeding, and 1 patient had ascites with Budd-Chiari syndrome. Two hundred patients (Child A, 24 patients; Child B, 62 patients; Child C, 114 patients) received TIPS shunts. One hundred forty-nine patients had refractory variceal bleeding, and 51 patients had ascites, hydrothorax, or hepatorenal syndrome. Data were collected by prospective databases, protocol follow-up, and phone contact. Results. The 30-day mortality rate was 0% for surgical shunts and 26% for TIPS shunts; the overall survival rate was 86% (median follow-up, 36 months) for surgical shunts and 53% (median follow-up, 40 months) for TIPS shunts. For surgical shunts, the portal hypertensive rebleeding rate was 6.3%; the overall rebleeding rate was 14.3%. For TIPS shunts, the overall rebleeding rate was 25.5% (30-day, 9.4%; late, 22.4%). There were 4 reinterventions for surgical shunts (6.3%); the reintervention rate for TIPS shunts in the bleeding group was 33%, and the reintervention rate in the ascites group was 9.5%. Encephalopathy was severe in 3.1% of the shunt group and mild in 17.5%; this was not systematically evaluated in the TIPS shunts patients. Conclusions. Surgical shunts still have a role for patients whose condition was classified as Child A and B with refractory bleeding, who achieve excellent outcomes with low morbidity and mortality rates. TIPS shunts have been used in high-risk patients with significant early and late mortality rates and have been useful in the control of refractory bleeding and as a bridge to transplantation. The comparative role of TIPS shunts versus surgical shunt in patients whose condition was classified as Child A and B is under study in a randomized controlled trial. (Surgery 2000;128:540-7.)
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Surgery
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Starzl TE
        • Demetris AJ
        • Van Thiel D.
        Liver transplantation.
        N Engl J Med. 1989; 321: 1014-1022
        • Henderson JM
        • Barnes DS
        • Geisinger MA.
        Portal hypertension.
        Curr Probl Surg. 1998; 35: 379-452
        • Lucey MR
        • Brown KA
        • Everson GT
        • et al.
        Minimal criteria for placement of adults on the liver transplant waiting list: a report of a national conference organized by the American Society of Transplant Physicians and the American Association for the Study of Liver Diseases.
        Liver Transpl Surg. 1997; 3 ([letter]): 628-637
        • Henderson JM
        • Boyer TD.
        The criteria for liver transplantation vary widely throughout the United States.
        Liver Transpl Surg. 1998; 4: 251
        • Rossle M
        • Haag K
        • Ochs A
        • et al.
        The transjugular intrahepatic portosystemic stent-shunt procedure for variceal bleeding.
        N Engl J Med. 1994; 330: 165-171
        • Ochs A
        • Rossle M
        • Haag K
        • et al.
        The transjugular intrahepatic portosystemic stent-shunt procedure for refractory ascites.
        N Engl J Med. 1995; 332: 1191-1197
        • Barton RE
        • Rosch J
        • Saxon RR
        • Lakin PC
        • Petersen BD
        • Keller KS.
        TIPS: short-and-long-term results: a survey of 1750 patients.
        Semin Interv Radiol. 1995; 12: 364-367
        • LaBerge JM
        • Somberg KA
        • Lake JR
        • et al.
        Two-year outcome following transjugular intrahepatic portosystemic shunt for variceal bleeding: results in 90 patients.
        Gastroenterology. 1995; 108: 1143-1151
        • Papatheodoridis GV
        • Goulis J
        • Leandro G
        • Patch D
        • Burroughs AK.
        Transjugular intrahepatic portosystemic shunt compared with endoscopic treatment for prevention of variceal rebleeding: a meta-analysis.
        Hepatology. 1999; 30: 612-622
        • Luca A
        • D'Amico G
        • LaGalla R
        • Midiri
        • Morabito A
        • Pagliaro L
        TIPS for prevention of recurrent bleeding in patients with cirrhosis: meta-analysis of randomized clinical trials.
        Radiology. 1999; 212: 411-421
        • Rosemurgy AS
        • Goode SE
        • Zwiebel BR
        • Black TJ
        • Brady PG.
        A prospective trial of transjugular intrahepatic portosystemic stent shunts versus small-diameter prosthetic H-graft portacaval shunts in the treatment of bleeding varices.
        Ann Surg. 1996; 224: 378-384
        • Stiegmann GV
        • Goff JS
        • Michaletz-Onody PA
        • et al.
        Endoscopic sclerotherapy as compared with endoscopic ligation for bleeding esophageal varices.
        N Engl J Med. 1992; 326: 1527-1532
        • Laine L
        • Cook D.
        Endoscopic ligation compared with sclerotherapy for treatment of esophageal variceal hemorrhage.
        Ann Intern Med. 1995; 123: 280-287
        • Arroya V
        • Gines P
        • Rodes J.
        Treatment of ascites in patients with cirrhosis of the liver.
        J Hepatol. 1986; 2: 504-512
        • Henderson JM
        • Rikkers LF.
        Atlas of liver surgery.
        in: Digestive tract surgery: a text and atlas. Lippincott-Raven, Philadelphia1996: 735-813
        • Atta HM
        • Henderson JM
        • Galloway JR
        • Millikan WJ.
        Selective splenocaval shunt: report of 26 cases and review of literature.
        Arch Surg. 1991; 126: 582-585
        • Rikkers LF
        • Jin G
        • Langnas AN
        • Shaw Jr., BW
        Shunt surgery during the era of liver transplantation.
        Ann Surg. 1997; 226: 51-57
        • Orozco H
        • Mercado MA
        • Granados Garcia J
        • et al.
        Selective shunts for portal hypertension: current role of a 21-year experience.
        Liver Transpl Surg. 1997; 3: 475-480
        • Jenkins RL
        • Gedaly R
        • Pomposelli JJ
        • Pomfred EA
        • Gordon F
        • Lewis WD.
        Distal splenorenal shunt: role, indications, and utility in the era of liver transplantation.
        Arch Surg. 1999; 134: 416-420
        • Knechtle SJ
        • D'Alessandro AM
        • Armbrust MJ
        • Musat A
        • Kalayoglu M
        Surgical portosystemic shunts for treatment of portal hypertensive bleeding: outcome and effect on liver function.
        Surgery. 1999; 126: 708-711
        • Rossle M
        • Siegerstetter V
        • Huber M
        • Ochs A.
        The first decade of the transjugular intrahepatic portosystemic shunt (TIPS): state of the art.
        Liver. 1998; 18: 73-89
        • Henderson JM
        • Kutner MH
        • Millikan WJ
        • et al.
        Endoscopic variceal sclerosis compared with distal splenorenal shunt to prevent recurrent variceal bleeding in cirrhosis.
        Ann Int Med. 1990; 112: 262-269
        • Henderson JM
        • Hooks M
        • Galloway JR
        • et al.
        Selective shunt in the management of variceal bleeding in the era of liver transplantation.
        Ann Surg. 1992; 216: 248-255
        • Hermann RE
        • Henderson JM
        • Vogt DP
        • Mayes JT
        • Geisinger MA
        • Agnor C.
        Fifty years of surgery for portal hypertension at the Cleveland Clinic Foundation.
        Ann Surg. 1995; 221: 459-468
        • Selim N
        • Fendley MJ
        • Boyer TD
        • Galloway JR
        • Branum GD.
        Conversion of failed transjugular intrahepatic portosystemic shunt to distal splenorenal shunt in patients with Child A or B cirrhosis.
        Ann Surg. 1998; 227: 600-603